Showing 441 - 460 results of 60,170 for search '(( e point decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.08s Refine Results
  1. 441
  2. 442
  3. 443
  4. 444
  5. 445

    H + D<sub>2</sub> Reaction Dynamics in the Limit of Low Product Recoil Energy by J. Aldegunde (1373448)

    Published 2015
    “…Both experiment and theory recently showed that the H + D<sub>2</sub>(<i>v</i> = 0, <i>j</i> = 0) → HD­(<i>v</i>′ = 4, <i>j</i>′) + D reactions at a collision energy of 1.97 eV display a seemingly anomalous HD product angular distribution that moves in the backward direction as the value of <i>j</i>′ increases and the corresponding energy available for product recoil decreases. …”
  6. 446

    The TLR4 activator LPS decreases photoreceptor viability and reducesWnt-mediated protection from oxidative stress. by Hyun Yi (57741)

    Published 2012
    “…<p>(A) Muller glia-photoreceptor cultures were incubated for 24 hr in 0.4 mM H<sub>2</sub>O<sub>2</sub> to induce oxidative stress, with and without recombinant Wnt3a (150 ng/ml) or the TLR4 activator LPS (5 and 50 µg/ml). …”
  7. 447

    The decrease in lactate induced by pyruvate is blocked by inhibition of MAS and of the TCA cycle in HKI/HKII double KD cells. by Scott John (228011)

    Published 2023
    “…This fast inhibitory phase was followed by a sustained one leading to intracellular lactate accumulation (phase 5). We will address the latter phase in a subsequent publication. …”
  8. 448

    Supplementary Material for: Decrease of Hyperintense Vessels on Fluid-Attenuated Inversion Recovery Predicts Good Outcome in t-PA Patients by Sakuta K. (4147642)

    Published 2016
    “…However, the clinical meaning of changes in HV is yet to be clarified. Here, we investigated serial changes to HV in patients with AIS who received tissue plasminogen activator (t-PA) therapy. …”
  9. 449
  10. 450

    PDGF-BB maintains Bcl2/Bax ratio and decreases caspase-3 activation induced by Tat and morphine. by Shaily Malik (226661)

    Published 2011
    “…<p>(A) Human neurons were treated with 100 ng/ml Tat and/or 100 nM morphine for 12 hours with or without pre-treatment with 40 ng/ml PDGF-BB. …”
  11. 451

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…Representative values of at least two independent experiments. <i>Columns,</i> mean; <i>bars</i>, s.d. E) eRMS RD cells were treated during 24 hours with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”
  12. 452
  13. 453
  14. 454
  15. 455
  16. 456
  17. 457

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.…”
  18. 458
  19. 459
  20. 460